startup.bid
NO
EnglishEspañolPortuguêsFrançaisDeutschItalianoNederlandsSvenskaDanskNorskPolskiSlovenščinaTürkçeРусскийBahasa IndonesiaBahasa MelayuFilipinoTiếng ViệtKiswahiliहिन्दीاردوالعربيةעברית日本語한국어中文繁體中文

Bikanta

Nano-diamonds for cancer detection

Nedlagt

Om selskapet

Selskapsbeskrivelse på engelsk

Bikanta is introducing revolutionary nanodiamond-based technology to push the boundaries of current medical imaging and diagnostics, allowing researchers to answer questions and medics to detect diseases that they currently cannot.

A nanodiamond is forever. They are brightly fluorescent, infinitely stable, non-toxic, functionalizable and can be used for background-free optical imaging. Early results have improved the signal by as much as 100-fold over conventional fluorescence imaging techniques. Bikanta’s vision is to redefine the boundaries of medical diagnostics by delivering cutting-edge imaging probes and background-free optical imaging.

Emner

NanomedicineHealthcareDiagnostics
Sted
San Francisco, CA, USA
Teamstørrelse
2 ansatte
YC-kull
Summer 2014
Status
Nedlagt
Fase
Tidlig fase

Lignende startups og konkurrenter

Spørsmål og svar

Hvor holder Bikanta til?

San Francisco, CA, USA

Hvor mange jobber i Bikanta?

Antall ansatte ifølge selskapsprofilen: 2.

Har Bikanta hentet kapital?

Det finnes ingen investeringsrunder for Bikanta i våre data.

Hvilke alternativer finnes til Bikanta?

Lignende startups: Opentrons, Eden og VenoStent.